Magnetic tracer compositions
Disclosed herein are pharmacologically acceptable magnetic nanoparticles suitable for administration to a subject. The magnetic nanoparticles have a pharmacologically acceptable polymer composition coating. The polymer composition coating comprises a polymeric steric stabiliser that promotes dispers...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
02.09.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Disclosed herein are pharmacologically acceptable magnetic nanoparticles suitable for administration to a subject. The magnetic nanoparticles have a pharmacologically acceptable polymer composition coating. The polymer composition coating comprises a polymeric steric stabiliser that promotes dispersion of the magnetic nanoparticles in a liquid, the polymeric steric stabiliser comprising (i) an anchoring polymer segment having one or more binding group that bind the polymeric steric stabiliser to the magnetic nanoparticles, and (ii) a steric stabilising polymer segment. The polymer composition coating also comprises:a polymeric targeting moiety comprising (i) an anchoring polymer segment having one or more binding group that bind the polymeric targeting moiety to the magnetic nanoparticles, and (ii) one or more targeting group for selectively targeting specific sites in the subject upon administration of the dispersion; and optionally a polymeric luminescent moiety comprising (i) an anchoring polymer segment having one or more binding group that bind the polymeric luminescent moiety to the magnetic nanoparticles, and (ii) one or more luminescent group for emitting light or an acoustic signal in response to light that enables in vivo location visualisation of the nanoparticles. |
---|---|
Bibliography: | Application Number: AU20200387750 |